{"id":668,"date":"2014-07-29T20:47:02","date_gmt":"2014-07-29T20:47:02","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=668"},"modified":"2026-02-25T19:42:50","modified_gmt":"2026-02-25T19:42:50","slug":"genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2014\/07\/29\/genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy\/","title":{"rendered":"Genetic architectures of ADME genes in five Eurasian admixed populations and implications for drug safety and efficacy (Contributed by Dr. Shuhua Xu)"},"content":{"rendered":"

The genetic heterogeneity can lead to heterogeneous drug responses among individuals, such as less efficacy or unwanted side effects of drug therapy. Moreover, the ethnic\/genetic diversity also affects the effective prescription. Here, we investigated the genetic diversity of 282 ADME genes in five northwestern Chinese minority populations which are all admixed people with ancestry contributions from both Eastern and Western Eurasian populations. We revealed that substantial allelic and haplotype differences exist at drug related genes between those minority ethnic groups and Han Chinese, which is likely to violate a single, unified standard of medication in China. (http:\/\/jmg.bmj.com\/content\/early\/2014\/07\/29\/jmedgenet-2014-102530<\/a> )<\/p>\n","protected":false},"excerpt":{"rendered":"

The genetic heterogeneity can lead to heterogeneous drug responses among individuals, such as less efficacy or unwanted side effects of drug therapy. Moreover, the ethnic\/genetic diversity also affects the effective prescription. Here, we investigated the genetic diversity of 282 ADME genes in five northwestern Chinese minority populations which are all admixed people with ancestry contributions […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-668","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nGenetic architectures of ADME genes in five Eurasian admixed populations and implications for drug safety and efficacy (Contributed by Dr. Shuhua Xu) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2014\/07\/29\/genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Genetic architectures of ADME genes in five Eurasian admixed populations and implications for drug safety and efficacy (Contributed by Dr. Shuhua Xu) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"The genetic heterogeneity can lead to heterogeneous drug responses among individuals, such as less efficacy or unwanted side effects of drug therapy. Moreover, the ethnic\/genetic diversity also affects the effective prescription. Here, we investigated the genetic diversity of 282 ADME genes in five northwestern Chinese minority populations which are all admixed people with ancestry contributions [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2014\/07\/29\/genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2014-07-29T20:47:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-25T19:42:50+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2014\\\/07\\\/29\\\/genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2014\\\/07\\\/29\\\/genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"Genetic architectures of ADME genes in five Eurasian admixed populations and implications for drug safety and efficacy (Contributed by Dr. Shuhua Xu)\",\"datePublished\":\"2014-07-29T20:47:02+00:00\",\"dateModified\":\"2026-02-25T19:42:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2014\\\/07\\\/29\\\/genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy\\\/\"},\"wordCount\":126,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2014\\\/07\\\/29\\\/genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2014\\\/07\\\/29\\\/genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2014\\\/07\\\/29\\\/genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy\\\/\",\"name\":\"Genetic architectures of ADME genes in five Eurasian admixed populations and implications for drug safety and efficacy (Contributed by Dr. Shuhua Xu) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"datePublished\":\"2014-07-29T20:47:02+00:00\",\"dateModified\":\"2026-02-25T19:42:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2014\\\/07\\\/29\\\/genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2014\\\/07\\\/29\\\/genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2014\\\/07\\\/29\\\/genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Genetic architectures of ADME genes in five Eurasian admixed populations and implications for drug safety and efficacy (Contributed by Dr. Shuhua Xu)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Genetic architectures of ADME genes in five Eurasian admixed populations and implications for drug safety and efficacy (Contributed by Dr. Shuhua Xu) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2014\/07\/29\/genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy\/","og_locale":"en_US","og_type":"article","og_title":"Genetic architectures of ADME genes in five Eurasian admixed populations and implications for drug safety and efficacy (Contributed by Dr. Shuhua Xu) - JMG Contact blog","og_description":"The genetic heterogeneity can lead to heterogeneous drug responses among individuals, such as less efficacy or unwanted side effects of drug therapy. Moreover, the ethnic\/genetic diversity also affects the effective prescription. Here, we investigated the genetic diversity of 282 ADME genes in five northwestern Chinese minority populations which are all admixed people with ancestry contributions [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2014\/07\/29\/genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy\/","og_site_name":"JMG Contact blog","article_published_time":"2014-07-29T20:47:02+00:00","article_modified_time":"2026-02-25T19:42:50+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2014\/07\/29\/genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2014\/07\/29\/genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"Genetic architectures of ADME genes in five Eurasian admixed populations and implications for drug safety and efficacy (Contributed by Dr. Shuhua Xu)","datePublished":"2014-07-29T20:47:02+00:00","dateModified":"2026-02-25T19:42:50+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2014\/07\/29\/genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy\/"},"wordCount":126,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2014\/07\/29\/genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2014\/07\/29\/genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy\/","url":"https:\/\/blogs.bmj.com\/jmg\/2014\/07\/29\/genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy\/","name":"Genetic architectures of ADME genes in five Eurasian admixed populations and implications for drug safety and efficacy (Contributed by Dr. Shuhua Xu) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"datePublished":"2014-07-29T20:47:02+00:00","dateModified":"2026-02-25T19:42:50+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2014\/07\/29\/genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2014\/07\/29\/genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2014\/07\/29\/genetic-architectures-of-adme-genes-in-five-eurasian-admixed-populations-and-implications-for-drug-safety-and-efficacy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"Genetic architectures of ADME genes in five Eurasian admixed populations and implications for drug safety and efficacy (Contributed by Dr. Shuhua Xu)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/668","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=668"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/668\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=668"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=668"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=668"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}